# The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2023, Regulation 26: Amendment to the Market Surveillance (Northern Ireland) Regulations 2021


In the Market Surveillance (Northern Ireland) Regulations 2021, Schedule 1 (investigatory powers) is amended as follows—
(a) in paragraph 1, after the definition of “Regulation (EU) 2017/745 on medical devices” insert—
““Regulation (EU) 2017/746 on in vitro diagnostic medical devices” means Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU.”;
(b) in paragraph 16—
(i) for sub-paragraph (2) substitute—
“(2) The officer may decommission or switch off any medical device to which the Medical Devices Regulations 2002, Regulation (EU) 2017/745 on medical devices or Regulation (EU) 2017/746 on in vitro diagnostic medical devices apply which is installed at a given location.”;
(ii) at the end of sub-paragraph (3)(a)(iv) omit “and” and insert—
“(v) Regulation (EU) 2017/746 on in vitro diagnostic medical devices; and”.

---
Source: https://www.legislation.gov.uk/ukdsi/2023/9780348253696/regulation/26 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-in-vitro-diagnostic-devices-etc-amendment-regulations-2023/regulation-26
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.